Jasper Therapeutics (JSPR)
(Delayed Data from NSDQ)
$21.60 USD
+1.68 (8.43%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $21.62 +0.02 (0.09%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-1.09 | -9.17% |
Earnings Summary
For their last quarter, Jasper Therapeutics (JSPR) reported earnings of -$1.03 per share, beating the Zacks Consensus Estimate of $-1.26 per share. This reflects a positive earnings surprise of 18.25%. Look out for JSPR's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$1.09 per share, reflecting a year-over-year increase of 27.33%.
Earnings History
Price & Consensus
Zacks News for JSPR
Jasper Therapeutics (JSPR) Is a Great Choice for 'Trend' Investors, Here's Why
JSPR: What are Zacks experts saying now?
Zacks Private Portfolio Services